Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the isosorbide class of organic polycyclic compounds. It features two amidinophenyl groups attached to a dianhydrosorbitol (isosorbide) core. The molecule has been studied as an experimental ligand and is listed in pharmaceutical compound libraries such as ZINC15 and DrugBank (DB04793). It has been used in structural biology studies as ligand TL4 but does not have any known approved therapeutic use or established mechanism of action in humans. Its primary relevance appears to be as a research tool or chemical probe rather than a marketed drug[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 1,4:3,6-dianhydro-2-o-(3-carbamimidoylphenyl)-5-o-(4-carbamimidoylphenyl)-d-glucitol.